Intraoperative localization of lymph node metastases with a replication-competent herpes simplex virus

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 5, 2006, Pages

  Adusumilli, Prasad S ^a   Eisenberg, David P ^a   Stiles, Brendon M ^a   Chung, Sun ^a   Chan, Mei Ki ^a   Rusch, Valerie W ^a   Fong, Yuman ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CERVICAL LYMPH NODE; CONTROLLED STUDY; CYTOTOXICITY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LAPAROSCOPY; LYMPH NODE METASTASIS; MALE; MALIGNANT MESOTHELIOMA; MEDIASTINUM LYMPH NODE; MOUSE; NONHUMAN; NUDE MOUSE; PARAAORTIC LYMPH NODE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEREOCHEMISTRY; THORACOSCOPY; TRANSGENE; VIRUS REPLICATION;

EID: 33750082718     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.07.005     Document Type: Article

References (37)

1. K.H. Antman Natural history and epidemiology of malignant mesothelioma Chest 103 suppl 1993 373S 376S
2. D.J. Sugarbaker R.M. Flores M.T. Jaklitsch W.G. Richards G.M. Strauss J.M. Corson Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients J Thorac Cardiovasc Surg 117 1999 54 63
3. J.E. Pilling D.J. Stewart A.E. Martin-Ucar S. Muller K.J. O’Byrne D.A. Waller The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma Eur J Cardiothorac Surg 25 2004 497 501
4. R.T. Heelan V.W. Rusch C.B. Begg D.M. Panicek J.F. Caravelli C. Eisen Staging of malignant pleural mesothelioma: comparison of CT and MR imaging AJR Am J Roentgenol 172 1999 1039 1047
5. R.M. Flores T. Akhurst M. Gonen S.M. Larson V.W. Rusch Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma J Thorac Cardiovasc Surg 126 2003 11 16
6. P.A. Janne E.H. Baldini Patterns of failure following surgical resection for malignant pleural mesothelioma Thorac Surg Clin 14 2004 567 573
7. J.M. Alvarez T. Ha W. Musk P. Robins R. Price M.J. Byrne Importance of mediastinoscopy, bilateral thoracoscopy, and laparoscopy in correct staging of malignant mesothelioma before extrapleural pneumonectomy J Thorac Cardiovasc Surg 130 2005 905 906
8. D.C. Rice J.J. Erasmus C.W. Stevens A.A. Vaporciyan J.S. Wu A.S. Tsao Extended surgical staging for potentially resectable malignant pleural mesothelioma Ann Thorac Surg 80 2005 1988 1992
9. P.S. Adusumilli M.K. Chan Y.S. Chun M. Hezel T.C. Chou V.W. Rusch Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma Cancer Biol Ther 5 2006 48 53
10. P.S. Adusumilli D.P. Eisenberg Y.S. Chun K.W. Ryu L. Ben-Porat K.J. Hendershott Virally directed fluorescent imaging improves diagnostic sensitivity in the detection of minimal residual disease after potentially curative cytoreductive surgery J Gastrointest Surg 9 2005 1138 1147
11. P.S. Adusumilli B.M. Stiles M.K. Chan M. Mullerad D.P. Eisenberg L. Ben-Porat Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses J Gene Med 8 2006 603 615
12. J.C. Kucharczuk B. Randazzo M.Y. Chang K.M. Amin A.A. Elshami D.H. Sterman Use of a “replication-restricted” herpes virus to treat experimental human malignant mesothelioma Cancer Res 57 1997 466 471
13. R.G. van der Most B.W. Robinson D.J. Nelson Gene therapy for malignant mesothelioma: beyond the infant years Cancer Gene Ther 2006 [epub ahead of print]
14. D.H. Sterman A. Recio A. Vachani J. Sun L. Cheung P. DeLong Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy Clin Cancer Res 11 2005 7444 7453
15. B. Everts H.G. van der Poel Replication-selective oncolytic viruses in the treatment of cancer Cancer Gene Ther 12 2005 141 161
16. E. Lou Oncolytic herpes viruses as a potential mechanism for cancer therapy Acta Oncol 42 2003 660 671
17. Y. Shen J. Nemunaitis Herpes simplex virus 1 (HSV-1) for cancer treatment Cancer Gene Ther 2006 [epub ahead of print]
18. R.J. Wong J.K. Joe S.H. Kim J.P. Shah B. Horsburgh Y. Fong Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases Hum Gene Ther 13 2002 1213 1223
19. P.S. Adusumilli B.M. Stiles M.K. Chan T.C. Chou R.J. Wong V.W. Rusch Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer Ann Thorac Surg 80 2005 409 416
20. D.H. Sterman J. Treat L.A. Litzky K.M. Amin L. Coonrod K. Molnar-Kimber Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma Hum Gene Ther 9 1998 1083 1092
21. Y. Ino Y. Saeki H. Fukuhara T. Todo Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy Clin Cancer Res 12 2006 643 652
22. S.F. Stanziale B.M. Stiles A. Bhargava S.A. Kerns N. Kalakonda Y. Fong Oncolytic herpes simplex virus-1 mutant expressing green fluorescent protein can detect and treat peritoneal cancer Hum Gene Ther 15 2004 609 618
23. P.S. Adusumilli B.M. Stiles M.K. Chan D.P. Eisenberg Z. Yu S.F. Stanziale Real-time diagnostic imaging of tumors and metastases by use of a replication-competent herpes vector to facilitate minimally-invasive oncological surgery FASEB J 20 2006 726 728
24. B. Stiles P. Adusumilli A. Bhargava S. Stanziale T. Kim M. Chan Minimally-invasive localization of oncolytic herpes simplex viral therapy of micrometastatic pleural cancer Cancer Gene Ther 13 2006 53 64
25. A. Sharma P. Fidias L.A. Hayman S.L. Loomis K.H. Taber S.L. Aquino Patterns of lymphadenopathy in thoracic malignancies Radiographics 24 2004 419 434
26. V.W. Rusch E.S. Venkatraman Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically Ann Thorac Surg 68 1999 1799 1804
27. E.H. Baldini A. Recht G.M. Strauss M.M. DeCamp Jr S.J. Swanson M.J. Liptay Patterns of failure after trimodality therapy for malignant pleural mesothelioma Ann Thorac Surg 63 1997 334 338
28. P.S. Adusumilli D.P. Eisenberg B.M. Stiles K.J. Hendershott S.F. Stanziale M.K. Chan Virally-directed fluorescent imaging (VFI) can facilitate endoscopic staging Surg Endosc 20 2006 628 635
29. B.M. Stiles A. Bhargava P.S. Adusumilli S.F. Stanziale T.H. Kim V.W. Rusch The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer Surgery 134 2003 357 364
30. S.J. Hughes L. Xi S. Raja W. Gooding D.J. Cole W.E. Gillanders A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer Ann Surg 243 2006 389 398
31. D.P. Eisenberg P.S. Adusumilli K.J. Hendershott S. Chung Z. Yu M.K. Chan Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus Ann Surg 243 2006 824 832
32. B. Meignier B. Martin R. Whitley B. Roizman In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. 11 Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivigatus) J Infect Dis 162 1999 313 321
33. T. Todo F. Feigenbaum S.D. Rabkin F. Lakeman J.T. Newsome P.A. Johnson Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus Mol Ther 2 2000 588 595
34. R. Rampling G. Cruickshank V. Papanastassiou J. Nicoll D. Hadley D. Brennan Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma Gene Ther 7 2000 859 866
35. J.M. Markert M.D. Medlock S.D. Rabkin G.Y. Gillespie T. Todo W.D. Hunter Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial Gene Ther 7 2000 867 874
36. D.S. Latchman Herpes simplex virus-based vectors for the treatment of cancer and neurodegenerative disease Curr Opin Mol Ther 7 2005 415 418
37. R. Chari S. Gevargheese J. Nemunaitis Y. Fong K. Tanabe E. Galanis A phase I/II, open-label study (with a sequential dose escalation stage followed by an expansion of a selected dose cohort), to evaluate the safety and anti-tumor effects of an oncolytic Herpes simplex virus, NV1020, administered repeatedly via hepatic artery infusion prior to second-line chemotherapy, in patients with colorectal adenocarcinoma metastatic to the liver 2006 Abstract presented at Digestive Diseases Week, May 20-25, Los Angeles, California